Author:
Abken H.,Hombach A.,Heuser C.,Reinhold U.
Publisher
Springer Berlin Heidelberg
Reference42 articles.
1. Abken H, Hombach A, Reinhold U, Ferrone S (1998) Can combined T-cell-and antibody-based immunotherapy outsmart tumor cells? Immunol Today 19: 2–5
2. Bajorin DF, Chapman PB, Wong G, Coit DG, Kunicka J, Dimaggio J, Cordon-Cardo C, Urmacher C, Dantes L, Templeton MA, Liu J, Oettgen HF, Houghton AN (1990) Phase I evaluation of a combination of monoclonal antibody R24 and interleukin-2 in patients with metastatic melanoma. Cancer Res 50: 7490–7495
3. Barnhill RL, Piepkorn MW, Alistair JC, Flynn E, Karaoli T, Folkman J (1998) Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 134: 991–994
4. Becker IC, Pancook JD, Gillies SD, Furukawa K, Reisfeld RA (1996a) T-cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin-2 therapy. J Exp Med 183: 2361–2366
5. Becker JC, Varki NM, Gillies SD, Furukawa K, Reisfeld RA (1996b) An antibody-interleukin2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. Proc Natl Acad Sci USA 93: 7826–7831
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献